Sy Ha

23.5k total citations · 2 hit papers
341 papers, 14.3k citations indexed

About

Sy Ha is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sy Ha has authored 341 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Hematology, 93 papers in Genetics and 57 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sy Ha's work include Acute Myeloid Leukemia Research (77 papers), Hemoglobinopathies and Related Disorders (66 papers) and Acute Lymphoblastic Leukemia research (53 papers). Sy Ha is often cited by papers focused on Acute Myeloid Leukemia Research (77 papers), Hemoglobinopathies and Related Disorders (66 papers) and Acute Lymphoblastic Leukemia research (53 papers). Sy Ha collaborates with scholars based in China, Hong Kong and United Kingdom. Sy Ha's co-authors include Gcf Chan, Stephen P. Pereira, Harpreet Wasan, Juan W. Valle, John Bridgewater, Alan Anthoney, David Cunningham, Anthony Maraveyas, S. Hughes and Srinivasan Madhusudan and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Sy Ha

328 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

2010 3.0k citations Sy Ha et al. profile →
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

2010 601 citations Sy Ha, Martín Cowie et al. profile →

Peers

Countries citing papers authored by Sy Ha

Since Specialization

Citations

This map shows the geographic impact of Sy Ha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sy Ha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sy Ha more than expected).

Fields of papers citing papers by Sy Ha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sy Ha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sy Ha. The network helps show where Sy Ha may publish in the future.

Co-authorship network of co-authors of Sy Ha

This figure shows the co-authorship network connecting the top 25 collaborators of Sy Ha. A scholar is included among the top collaborators of Sy Ha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sy Ha. Sy Ha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized Trial of Osilodrostat for the Treatment of Cushing Disease 2022 ·The Journal of Clinical Endocrinology & Metabolism ·Mônica R. Gadelha, Marie Bex, Richard A. Feelders, Anthony P. Heaney, Richard J. Auchus, Aleksandra Gilis‐Januszewska, Przemysław Witek, Zhanna Belaya, Yerong Yu, (unknown), (unknown), Davide Carvalho, Sy Ha, (unknown), Alberto M Pedroncelli, Peter J. Snyder	66
2	Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium 2022 ·British Journal of Haematology ·(unknown), Gertjan J.L. Kaspers, Jonas Abrahamsson, Nira Arad‐Cohen, Daniela Cianci, José M. Fernández, Sy Ha, Henrik Hasle, Barbara De Moerloose, C. Michel Zwaan, Bianca F. Goemans	9
3	Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study 2019 ·Clinical Endocrinology ·Maria Fleseriu, Stephan Petersenn, Beverly M. K. Biller, Pınar Kadıoğlu, Christophe De Block, Guy T’Sjoen, Marie‐Christine Vantyghem, Libuse Tauchmanovà, (unknown), Sy Ha, André Lacroix, John Newell‐Price	29
4	Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO‐AML) and review of the literature 2018 ·Genes Chromosomes and Cancer ·(unknown), Ulrika Norén‐Nyström, Jonas Abrahamsson, Sy Ha, Cornelis Jan Pronk, Kirsi Jahnukainen, Ólafur G. Jónsson, Birgitte Lausen, Josefine Palle, Bernward Zeller, Lars Palmqvist, Henrik Hasle	22
5	Influence of Systolic Blood Pressure on Clinical Outcomes in Elderly Heart Failure Patients Treated with Nebivolol: Data from the SENIORS Trial 2014 ·European Journal of Heart Failure ·Manuel Montero-Pérez-Barquero, Marcus Flather, Sy Ha, Andrew J.S. Coats, Michael Böhm, Dirk J. van Veldhuisen, Daphne Babalis, Alain Cohen Solal, Luís Manzano	22
6	Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group 2013 ·Journal of Clinical Oncology ·Gertjan J.L. Kaspers, Martin Zimmermann, Dirk Reinhardt, Brenda Gibson, R. Y. J. Tamminga, Olga Aleinikova, (unknown), Michael Dworzak, Sy Ha, Henrik Hasle, Liisa Hovi, Alexei Maschan, Yves Bertrand, Guy Leverger, Bassem I. Razzouk, Carmelo Rizzari, Petr Smíšek, Owen Smith, Batia Stark, Ursula Creutzig	152
7	Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode Statistics 2013 ·Gut ·(unknown), (unknown), (unknown), (unknown), Richard Sturgess, (unknown), Sy Ha, Michael Pearson, Keith Bodger	52
8	Effect of Nebivolol on Outcome in Elderly Patients with Heart Failure and Atrial Fibrillation: Insights from SENIORS 2012 ·European Journal of Heart Failure ·Bart A. Mulder, Dirk J. van Veldhuisen, Harry J.G.M. Crijns, Michael Böhm, Alain Cohen‐Solal, Daphne Babalis, Sy Ha, Marcus Flather, Andrew J.S. Coats, Isabelle C. Van Gelder	51
9	PWE-244 Does thromboprophylaxis in ulcerative colitis work?: data from the UK IBD audit 2012 ·Gut ·(unknown), Sy Ha, (unknown), Ian Arnott	0
10	Anaemia Among Patients with Heart Failure and Preserved or Reduced Ejection Fraction: Results from the SENIORS Study 2011 ·European Journal of Heart Failure ·Stephan von Haehling, Dirk J. van Veldhuisen, Sy Ha, Daphne Babalis, Rudolf A. de Boer, Andrew J.S. Coats, Luís Manzano, Marcus Flather, Stefan D. Anker	50
11	Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer 2011 ·Journal of Clinical Oncology ·Allan Hackshaw, Sy Ha, Sharon Forsyth, Kathryn Monson, Krystyna Reczko, R Sainsbury, Michael Baum	68
12	Predictors of Clinical Outcomes in Elderly Patients with Heart Failure 2011 ·European Journal of Heart Failure ·Luís Manzano, Daphne Babalis, Sy Ha, Marcelo C. Shibata, Stefan D. Anker, Stefano Ghio, Dirk J. van Veldhuisen, Alain Cohen‐Solal, Andrew J.S. Coats, Philip Poole-Wilson, Marcus Flather	94
13	Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients 2011 ·Pediatric Blood & Cancer ·Wing Y. Au, Chi Kong Li, Vincent Lee, Hui Leung Yuen, (unknown), Gcf Chan, Sy Ha, Yok‐Lam Kwong	23
14	Circulating CD133+VEGFR2+ and CD34+VEGFR2+ cells and arterial function in patients with beta-thalassaemia major 2011 ·Annals of Hematology ·Yiu‐fai Cheung, (unknown), Mo Yang, Jieyu Ye, Sy Ha, Sophia J. Wong, Gcf Chan	2
15	A Randomized Trial of Home Telemonitoring in a Typical Elderly Heart Failure Population in North West London: Results of the Home-HF Study 2009 ·European Journal of Heart Failure ·Owais Dar, Jillian Riley, (unknown), Simon W Dubrey, Stephen Morris, Stuart D. Rosen, Sy Ha, Martín Cowie	118
16	Amplified proinflammatory and attenuated immunomodulatory T cells at the culprit site of ST elevation myocardial infarction may contribute to reperfusion injury 2008 ·European Heart Journal ·Gopal Ghimire, (unknown), Rajesh Kharbanda, Sy Ha, (unknown), Alice Mitchell, Charles Ilsley, Melanie J. Rose, Miles Dalby	1
17	Evidence for the return of coronary vasoreactivity following absorption of a bioabsorbable magnesium alloy coronary stent 2007 ·The American Journal of Cardiology ·Gopal Ghimire, (unknown), Rajesh Kharbanda, Sy Ha, Peter Barlis, Mark Mason, Charles Ilsley, Carlo Di Mario, R Erbel, (unknown), Miles Dalby	4
18	Management of spontaneously ruptured hepatoblastoma in infancy 2002 ·Medical and Pediatric Oncology ·Kok‐Lung Chan, S T Fan, Paul Tam, Aks Chiang, Gcf Chan, Sy Ha	10
19	Unrelated marrow donor registry for Chinese. 1997 ·PubMed ·Raymond Liang, (unknown), Frederick Chen, Yok‐Lam Kwong, Chor Sang Chim, W.Y. Au, Sy Ha, (unknown), (unknown), B. R. Hawkins	2
20	Cytogenetic abnormalities in pediatric myelodysplastic syndrome: A report of three cases 1997 ·Cancer Genetics and Cytogenetics ·(unknown), Sy Ha, Godfrey Chi Fung Chan, (unknown), YL Lau	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact